Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

tRNS in Anterior Cingulate Cortex Reduces Craving Over Dual Pathology Patients

NCT: NCT01876524 · COMPLETED

NCT IDNCT01876524
StatusCOMPLETED
Start Date2013-07
Completion2014-09

Brief Summary

The purpose of this study is to study the efficacy and security of noninvasive brain stimulation as a new approach for patients with Substance Use Disorders (SUDs) plus other psychiatric conditions like ADHD, Schizophrenia, Bipolar disorder, etc.

Frequently Asked Questions

What is tRNS in Anterior Cingulate Cortex Reduces Craving Over Dual Pathology Patients?

tRNS in Anterior Cingulate Cortex Reduces Craving Over Dual Pathology Patients is a clinical trial registered under NCT01876524. Current status: COMPLETED.

What is the status of NCT01876524?

The current status of NCT01876524 (tRNS in Anterior Cingulate Cortex Reduces Craving Over Dual Pathology Patients) is: COMPLETED.

When did tRNS in Anterior Cingulate Cortex Reduces Craving Over Dual Pathology Patients start?

tRNS in Anterior Cingulate Cortex Reduces Craving Over Dual Pathology Patients started on 2013-07.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑